Why treat anemia in the preoperative period of joint replacement surgery with erythropoietin? IMPACT consults. Proceedings of the 2nd Annual Cleveland Clinic Perioperative Medicine Summit.
Treatment of anemia in the perioperative period of major orthopedic surgery decreases the need for blood transfusion and improves perioperative outcomes. Use of epoetin alfa in this setting is FDA-approved and provides significant benefit to qualified and carefully chosen patients.
Kumar
Ajay
A
Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic, Cleveland, OH 44195, USA. kumara@ccf.org
Dimov
Vesselin
V
D000740:Anemia / Q000188:drug therapy*; D019643:Arthroplasty, Replacement; D001803:Blood Transfusion; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000627:therapeutic use*; D006397:Hematinics / Q000627:therapeutic use*; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control; D011300:Preoperative Care; D011994:Recombinant Proteins; D012306:Risk
D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa